Descripción del producto

Prasugrel Hydrochloride (*-[*-(Acetyloxy)*6,*-dihydrothieno[3,*-c]pyridin*5(4H)-yl]**-cyclopropyl**-(*-fluorophenyl)ethanone Hydrochloride; CS **7; Effient; LY *****5)

A novel antiplatelet agent; it is a third-generation thienopyridine. Antiplatelet agent Prasugrel showed greater platelet inhibition and decreased incidence of ischemic events than Clopidogrel but may induce increased incidence of bleeding in patients.

Method for Determining Identity

Proton NMR Spectroscopic and Mass Spectrometric Analysis

Related Substances 

Total≤1.0%

Individual≤0.5%

Loss on Drying

≤0.5%

Residue on Ignition

≤0.1%

Heavy Metals

≤0.**2%

Storage and Stability 

May be stored at RT for short-term only. Long-term storage is recommended at **0°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.

Toxicity and Hazards

Due to the potential danger associated with the use of some of United States Biological biochemicals, all products should be handled by qualified personnel only, trained in laboratory procedures, and familiar with potential hazards. Information is not available on the possible hazards of many experimental compounds. The absence of a warning must not be interpreted as indication of safety.



Formulation

Supplied as a light yellow or off white crystalline powder.



Purity

~*0%



Grade

Highly Purified



Storage

**0°C



MW

**9.9



Formula

C*0H*1CIFNO3S